These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10861611)

  • 1. Biological prognostic factors for early stage completely resected non-small cell lung cancer.
    Cagini L; Monacelli M; Giustozzi G; Moggi L; Bellezza G; Sidoni A; Bucciarelli E; Darwish S; Ludovini V; Pistola L; Gregorc V; Tonato M
    J Surg Oncol; 2000 May; 74(1):53-60. PubMed ID: 10861611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Di Carlo L; Semeraro A; Daddi G; Darwish S; Stocchi L; Tofanetti FR; Bellezza G; Sidoni A; Tognellini R; Crinò L; Tonato M
    Tumori; 2008; 94(3):398-405. PubMed ID: 18705409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer.
    Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
    Eur J Surg Oncol; 2003 Oct; 29(8):654-7. PubMed ID: 14511612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers.
    Grossi F; Loprevite M; Chiaramondia M; Ceppa P; Pera C; Ratto GB; Serrano J; Ferrara GB; Costa R; Boni L; Ardizzoni A
    Eur J Cancer; 2003 Jun; 39(9):1242-50. PubMed ID: 12763212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
    Pastorino U; Andreola S; Tagliabue E; Pezzella F; Incarbone M; Sozzi G; Buyse M; Menard S; Pierotti M; Rilke F
    J Clin Oncol; 1997 Aug; 15(8):2858-65. PubMed ID: 9256129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer.
    Paik KH; Park YH; Ryoo BY; Yang SH; Lee JC; Kim CH; Ki SS; Kim JM; Park MJ; Ahn HJ; Choi W; Chung JH
    J Korean Med Sci; 2006 Feb; 21(1):35-9. PubMed ID: 16479062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas.
    Li Y; Xu KP; Jiang D; Zhao J; Ge JF; Zheng SY
    Int J Clin Exp Pathol; 2015; 8(11):13978-86. PubMed ID: 26823709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery.
    Carbognani P; Tincani G; Crafa P; Sansebastiano G; Pazzini L; Zoni R; Bobbio A; Rusca M
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):545-8. PubMed ID: 12124571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis.
    Poleri C; Morero JL; Nieva B; Vázquez MF; Rodríguez C; de Titto E; Rosenberg M
    Chest; 2003 Jun; 123(6):1858-67. PubMed ID: 12796161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer.
    Lai RS; Wang JS; Hsu HK; Chang HC; Lin CH; Lin MH
    Jpn J Clin Oncol; 2002 Oct; 32(10):393-7. PubMed ID: 12451034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung.
    Minami K; Saito Y; Imamura H; Okamura A
    Lung Cancer; 2002 Oct; 38(1):51-7. PubMed ID: 12367793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer.
    Mehdi SA; Etzell JE; Newman NB; Weidner N; Kohman LJ; Graziano SL
    Lung Cancer; 1998 May; 20(2):99-108. PubMed ID: 9711528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
    Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ
    Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
    Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
    J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
    Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
    Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.